文献速递胃肠外科

机器人对比腹腔镜胃切除术治疗胃癌的长期肿瘤学结局:多中心队列研究

Long-term oncological outcomes of robotic versus laparoscopic gastrectomy for gastric cancer: multicentre cohort study.
PubMed 文献 · Br J Surg · 2024-01-01

这项多中心队列研究纳入2010年3月1日至2018年12月31日在中国10家高容量中心接受根治性胃切除术的胃癌患者,将机器人胃切除术(RG)与腹腔镜胃切除术(LG)按倾向性评分1:1匹配。匹配队列含2026例RG和2026例LG,中位随访RG组41个月、LG组39个月。RG组与LG组3年无病生存率分别为80.8%和79.5%,HR 0.92(95%CI 0.80-1.06,P=0.242),两组无病生存与总生存相当。

要点

  • 匹配队列含2026例RG和2026例LG,中位随访RG组41个月、LG组39个月。
  • 3年无病生存率RG组80.8% vs LG组79.5%(HR 0.92,95%CI 0.80-1.06,P=0.242)。
  • 3年总生存率RG组83.9% vs LG组81.8%(HR 0.87,95%CI 0.75-1.01,P=0.068),两组无病生存与总生存相当。

核心结论

  • 胃癌患者接受RG与LG的3年无病生存和总生存相当。

研究设计与样本

  • 多中心队列研究,纳入2010年3月1日至2018年12月31日中国10家高容量中心接受根治性胃切除术的胃癌患者,RG与LG按倾向性评分1:1匹配。
  • 共纳入2055例RG和4309例LG,匹配队列含2026例RG和2026例LG。

主要发现

  • RG组中位随访41(四分位距39-58)个月,LG组中位随访39(38-56)个月。
  • 3年无病生存率RG组80.8% vs LG组79.5%(log rank P=0.240;HR 0.92,95%CI 0.80-1.06;P=0.242)。
  • 3年总生存率RG组83.9% vs LG组81.8%(log rank P=0.068;HR 0.87,95%CI 0.75-1.01;P=0.068)。
  • 3年累积复发率RG组19.3% vs LG组20.8%(HR 0.95,95%CI 0.88-1.03;P=0.219),两组间无差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this multicentre cohort study was to compare the long-term oncological outcomes of robotic gastrectomy (RG) and laparoscopic gastrectomy (LG) for patients with gastric cancer. METHODS: Patients with gastric cancer who underwent radical gastrectomy by robotic or laparoscopic approaches from 1 March 2010 to 31 December 2018 at 10 high-volume centres in China were selected from institutional databases. Patients receiving RG were matched 1 : 1 by propensity score with patients undergoing LG. The primary outcome was 3-year disease-free survival. Secondary outcomes were overall survival and disease recurrence. RESULTS: Some 2055 patients who underwent RG and 4309 patients who had LG were included. The propensity score-matched cohort comprised 2026 RGs and 2026 LGs. Median follow-up was 41 (i.q.r. 39-58) months for the RG group and 39 (38-56) months for the LG group. The 3-year disease-free survival rates were 80.8% in the RG group and 79.5% in the LG group (log rank P = 0.240; HR 0.92, 95% c.i. 0.80 to 1.06; P = 0.242). Three-year OS rates were 83.9 and 81.8% respectively (log rank P = 0.068; HR 0.87, 0.75 to 1.01; P = 0.068) and the cumulative incidence of recurrence over 3 years was 19.3% versus 20.8% (HR 0.95, 0.88 to 1.03; P = 0.219), with no difference between groups. CONCLUSION: RG and LG in patients with gastric cancer are associated with comparable disease-free and overall survival.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Li ZY, Wei B, Zhou YB, et al. Long-term oncological outcomes of robotic versus laparoscopic gastrectomy for gastric cancer: multicentre cohort study. Br J Surg. 2024. PMID: 38215239. doi:10.1093/bjs/znad435

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。